4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001209191-21-059353
Chief Commercial Officer sold 3,058 shares at $24.77 ($75,746)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heerma Peter Chief Commercial Officer | 2021-10-04 | Sale | −3,058 | $24.77 | $75,746 | 60,457 | D |
| Open-market sales · 3,058 sh · avg $24.77 · $75,746 | |||||||
Loading xslF345X03/doc4.xml…